Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics and Zinc for GERD
NCT06664008Phase 4Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- Peptides, Orthosteric Ligands
01
Overview
A Phase 4 trial of polaprezinc in gastroesophageal reflux disease (GERD), sponsored by Ain Shams University. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
polaprezinc
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT06664008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06664008.